ENACT Act of 2021
Latest action · May 11, 2021 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 11, 2021
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021
This bill sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimer's disease and related dementias.
Specifically, the National Institute on Aging (NIA) must establish and provide technical assistance to Alzheimer's research centers located in areas with higher concentrations of minority groups. These centers must
- establish diagnostic and treatment clinics designed to serve minority, rural, and other underserved populations;
- operate clinical trials; and
- carry out public outreach to encourage members of minority populations to participate in clinical trials and research.
Additionally, the NIA must disseminate information to members of minority populations about participating in clinical trials and take other actions to enhance diversity with respect to the Alzheimer's research that it conducts or supports.
The bill also directs the NIA to increase diversity among Alzheimer's researchers by encouraging the participation of individuals who are from groups that are underrepresented in clinical, behavioral, and social sciences.
Cosponsors 18
Members who signed on, in the order they did. Signatures ran from May 11, 2021 to Sep 12, 2022; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-ME | Susan M. Collins | Original | May 11, 2021 |
| D-CO | Michael F. Bennet | May 27, 2021 | |
| D-PA | Robert P. Casey Jr. | Jun 17, 2021 | |
| I-AZ | Kyrsten Sinema | Oct 7, 2021 | |
| R-KS | Jerry Moran | Oct 26, 2021 | |
| D-MI | Debbie Stabenow | Nov 16, 2021 | |
| D-MN | Tina Smith | Nov 16, 2021 | |
| R-LA | Bill Cassidy | Dec 7, 2021 | |
| R-AR | John Boozman | Dec 7, 2021 | |
| D-MA | Edward J. Markey | May 4, 2022 | |
| D-MI | Gary C. Peters | May 4, 2022 | |
| R-MS | Roger F. Wicker | May 10, 2022 | |
| R-WV | Shelley Moore Capito | May 17, 2022 | |
| R-OK | James M. Inhofe | May 19, 2022 | |
| R-AK | Lisa Murkowski | May 19, 2022 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred May 11, 2021 |
Actions 2
Everything that happened, newest first.
- May 11, 2021Introduced in Senate
- May 11, 2021Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 117-55 | TAKING AIM AT ALZHEIMER'S: FRONTLINE PERSPECTIVES AND CAREGIVER CHALLENGES78 pages | Aging (Special) Committee | May 20, 2021 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 3085 | ENACT Act of 2021 | Identical bill | May 12, 2021 |
| S 4486 | Health Equity and Accountability Act of 2022 | Related bill | Jun 23, 2022 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Public Health Service Act to improve the diversity of participants in research on Alzheimer's disease, and for other purposes.
- Short Title(s) as Introduced
- ENACT Act of 2021
- Equity in Neuroscience and Alzheimer’s Clinical Trials Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- May 11, 2021Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.